<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Hormonal Contraceptives</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Hormonal Contraceptives</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                11 Questions | 11 Total Marks | 21 min Duration | ~114.55 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 11 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 21 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 11</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Hormonal Contraceptives - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 11</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 11 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Which of the following drugs is not indicated to treat female infertility?", "options": [{"label": "A", "text": "Clomiphene", "correct": false}, {"label": "B", "text": "Leuprolide", "correct": false}, {"label": "C", "text": "Goserelin", "correct": false}, {"label": "D", "text": "Raloxifene", "correct": true}], "correct_answer": "D. Raloxifene", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Raloxifene Raloxifene is not indicated to treat female infertility.</p>\n<p><strong>Highyeild:</strong></p><p>Raloxifene- Raloxifene is a Selective estrogen receptor modulator (SERM) Indications- A second-line drug for prevention and treatment of osteoporosis in postmenopausal women, Ca2+ and vit D supplements enhance the benefit. According to British guidelines, raloxifene is not recommended for primary prophylaxis of osteoporotic fractures in postmenopausal women but is an alternative option for secondary prevention and treatment of vertebral fractures , i.e. in those who have already suffered a fracture. It is also approved for the prevention of breast cancer in women with risk factors.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Clomiphene - Clomiphene citrate is used in the treatment of infertility , it acts by blocking negative feedback by estrogen and induces ovulation. Option: B. Leuprolide and C. Goserelin - are pulsatile GnRH agonists which can be used in the treatment of infertility.</p>\n<p><strong>Extraedge:</strong></p><p>Clomiphene - An estrogen receptor antagonist in most target tissues. Blockade of estrogen receptors in the hypothalamus counteracts the estrogen-induced negative feedback on the hypothalamic-pituitary-ovarian axis. This effect often allows normal pulsatility of gonadotropin-releasing hormone (GnRH) release from the hypothalamus to occur, stimulating a normal pattern of follicle-stimulating hormone(FSH) and luteinizing hormone (LH) release from the anterior pituitary , resulting in ovulation. The drug has been used for more than 25 years to treat infertility when other causes have been ruled out. However, clomiphene may exhibit negative effects, including an increased incidence of multiple births, ovarian cysts, and ovarian hyperstimulation syndrome.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Dose of ulipristal for emergency contraception?", "options": [{"label": "A", "text": "600mg", "correct": false}, {"label": "B", "text": "0.75mg", "correct": false}, {"label": "C", "text": "30mg", "correct": true}, {"label": "D", "text": "1.5mg", "correct": false}], "correct_answer": "C. 30mg", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>30mg The dose of ulipristal for emergency contraception is 30mg.</p>\n<p><strong>Highyeild:</strong></p><p>Ulipristal- A recently approved â€˜selective progesterone receptor modulatorâ€™ (SPRM) for use as an emergency contraceptive. Mechanism of action - Inhibits ovulation Suppresses LH surge Suppresses follicular rupture Action on endometrium can interfere with In clinical trials, the efficacy of ulipristal (30 mg) as an emergency contraceptive has been rated equal to that of levonorgestrel (1.5 mg) when taken within 72 hours of unprotected intercourse, and to be more effective when taken between 72â€“120 hours. Thus, it may have an advantage , if the woman misses taking the drug within 72 hours. Side effects Headache, nausea, vomiting, abdominal pain and menstrual delay ovarian cysts anti glucocorticoid</p>\n<p><strong>Extraedge:</strong></p><p>Eg.of SPRMS -Selective progesterone receptor modulators MIFEPRISTONE Progesterone Partial Agonist and Antagonist Glucocorticoid Receptor Antagonism Rx MTP, Abortions Emergency contraceptive Endometriosis Fibroids Cushingâ€™s syndrome Progesterone receptor-positive breast cancers Meningioma ULIPRISTAL Emergency Contraceptive</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Breakthrough bleeding is the most common problem with:", "options": [{"label": "A", "text": "Progesterone-only pill", "correct": true}, {"label": "B", "text": "Biphasic combined OCPs", "correct": false}, {"label": "C", "text": "Triphasic combined OCPs", "correct": false}, {"label": "D", "text": "Monophasic combined OCPs", "correct": false}], "correct_answer": "A. Progesterone-only pill", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Progesterone-only pill Breakthrough bleeding is the most common problem with Progesterone-only Episodes of irregular, unpredictable spotting and breakthrough bleeding are the most frequently encountered untoward effect and the major reason women discontinue the use of progesterone-only contraceptives.</p>\n<p><strong>Highyeild:</strong></p><p>Adverse effects of Oral Contraceptive Pills- Non Serious side effects- Nausea and vomiting Headache Mild Precipitate migraine Breakthrough bleeding /spotting especially with progestin- only preparations. Shifting to a triphasic pill may overcome the breakthrough bleeding. Rarely bleeding fails to occur during the gap period. Prolonged amenorrhoea or cycle disruption occurs in a few women taking injectables or mini pills. Especially with Progestin-only pills Breast discomfort Late side effects- Weight gain, acne, increased body hair Chloasma Pruritus vulvae Carbohydrate intolerance precipitation diabetes Mood swings Mental depression Abdominal distension Serious complications - Leg vein thrombosis and pulmonary embolism Coronary and cerebral thrombosis Myocardial infarction Stroke The estrogen component is responsible Increase in blood clotting factor decreased antithrombin3 decreased plasminogen activator in the endothelium increased platelet aggregation Rise in BP Genital carcinoma Increased vaginal, breast, and cervical cancer Benign hepatomas Gallstones</p>\n<p><strong>Extraedge:</strong></p><p>Centchroman (Ospemifene) - Nonsteroidal SERM(Selective Estrogen Receptor Modulator) an oral contraceptive. It has predominant estrogen antagonistic action in the uterus and breast with little action on the vaginal epithelium and cervical mucus. Endometrial proliferation is suppressed by the down-regulation of endometrial ER. Excessive bleeding attending anovulatory cycles is diminished & it is also approved for use in dysfunctional uterine bleeding. Contraceptive action is probably due to uterus-embryonic asynchrony and failure of implantation. For contraception- 30 mg twice a week for 12 weeks followed by once a week. Chhaya (8-centchroman tablet ) is provided free by the government of India.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The following are the non-contraceptive benefits of OCPs Except:", "options": [{"label": "A", "text": "Benign breast disease", "correct": false}, {"label": "B", "text": "Premenstrual tension syndrome", "correct": false}, {"label": "C", "text": "Ovarian cancer", "correct": false}, {"label": "D", "text": "Cervical cancer", "correct": true}], "correct_answer": "D. Cervical cancer", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Cervical cancer An increased incidence of vaginal, cervical, and breast cancers is seen with the use of OCPs.</p>\n<p><strong>Highyeild:</strong></p><p>Advantages of Oral Contraceptive Pills- Contraception Non-contraceptive advantages (mnemonic-Other Benefits) O varian cyst B enign breast disease E ctopic pregnancy N eoplasia ( Ovarian, Endometrial, colon cancer ) E ndometriosis F ibroid(Progestin-only pills) I ron deficiency anemia T ension (Premenstrual tension syndrome) S keletal (RA and Osteoporosis)</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "If a woman on combined pills missed 3 tablets in week 1 after HFI during the cycle, What should she do for contraception?", "options": [{"label": "A", "text": "Take two tablets the next day and continue the remaining pill as usual.", "correct": false}, {"label": "B", "text": "Take the missed pill as soon as possible and continue the remaining pill as usual, consider EC if UPSI has taken place.", "correct": true}, {"label": "C", "text": "Manage as a new start contraception", "correct": false}, {"label": "D", "text": "Take the missed pill as soon as possible and continue the remaining pill as usual, EC is not required even if UPSI has taken place.", "correct": false}], "correct_answer": "B. Take the missed pill as soon as possible and continue the remaining pill as usual, consider EC if UPSI has taken place.", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Take the missed pill as soon as possible and continue the remaining pill as usual, consider EC if UPSI has taken place. As the patient has missed 3 pills in week 1 she should Take the missed pill as soon as possible and continue the remaining pill as usual , consider EC if UPSI has taken place(As week 1 is the most important phase to suppress ovulation ).</p>\n<p><strong>Highyeild:</strong></p><p>FSRH CEU Guidance: Recommended Actions after Incorrect Use of Combined Hormonal Contraception (March 2020, Amended 6 July 2021) 21 DAYS PILL AND 7 DAYS HFI The first 7 days-pill suppress ovulation Next 14 days-pill maintain anovulation Guidance on actions after incorrect use of Combined Oral contraception Monophasic Combined Oral Contraceptives without placebo pills â— Late restarting after HFI â‰¥ 9 completed days since the last pill was taken Consider EC , if UPSI has taken place during/after HFI, âž¢    take the most recent missed pill as soon as possible. âž¢    continue the remaining pills at the usual time. âž¢ Condoms should be used or sex avoided until pills have been taken for 7 consecutive days. â— 1 missed pill in week 1 after HFI EC not required* âž¢    take the missed pill as soon as possible. âž¢    continue the remaining pills at the usual time. âž¢    No additional contraceptive precaution is needed. in week 2 or week 3 after HFI EC not required** â— 2-7 pills missed in week 1 after HFI Consider EC if UPSI has taken place during the HFI or week 1 âž¢    take the most recent missed pill as soon as possible. âž¢    continue the remaining pills at the usual time. âž¢ Condoms should be used or sex avoided until pills have been taken for 7 consecutive days. âž¢    Consider a follow-up pregnancy test. in week 2 or week 3 after HFI EC not required** âž¢    take the most recent missed pill as soon as possible. âž¢    continue the remaining pills at the usual time. âž¢ Condoms should be used or sex avoided until pills have been taken for 7 consecutive days. âž¢    If missed 7 days before HFI, omit the HFI. â— >7 consecutive pills missed ANY week Consider EC âž¢ Manage as a new start contraception âž¢    consider an immediate pregnancy test âž¢ quick start new COC packet âž¢ Condoms should be used or sex avoided until pills have been taken for 7 consecutive days. âž¢    Consider a follow-up pregnancy test. HFI-Hormone Free Interval UPSI-UnProtected Sexual Intercourse EC-Emergency contraceptive COC-Combined Oral contraception * if consistent, correct use earlier in week 1 and the 7 days before the HFI **If consistent, correct use in previous 7 days</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A Woman on combined OCPs was taking it irregularly in a cycle. She became pregnant and what advice did you give to her:", "options": [{"label": "A", "text": "Continue pregnancy", "correct": false}, {"label": "B", "text": "Termination of pregnancy", "correct": true}, {"label": "C", "text": "Switch to long-acting progesterone pills", "correct": false}, {"label": "D", "text": "None of the above", "correct": false}], "correct_answer": "B. Termination of pregnancy", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Termination of pregnancy If pregnancy occurs during the use of hormonal contraceptives it should be terminated by suction-aspiration because the risk of malformations , genital carcinoma in female offspring, and undescended testes in male offspring is increased.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Continuing pregnancy will be harmful to the fetus. Option: C. Switch to long-acting progesterone pills - In women with contraindications for estrogen, a progestin-only contraceptive may be used, but not in pregnant patients.</p>\n<p><strong>Extraedge:</strong></p><p>Mini Pill (Progesterone Only Pill) - Norethindrone - Used in Lactating mother Sickle cell anemia Seizures Smokers > 35 yr old Increased Venous Thromboembolism</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Among the following options, Danazol is not used to treat:", "options": [{"label": "A", "text": "Hirsutism", "correct": true}, {"label": "B", "text": "Gynecomastia", "correct": false}, {"label": "C", "text": "Endometriosis", "correct": false}, {"label": "D", "text": "Menorrhagia", "correct": false}], "correct_answer": "A. Hirsutism", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Hirsutism Hirsutism is a side effect of Danazol.</p>\n<p><strong>Highyeild:</strong></p><p>Danazol- An orally active isoxazole derivative of ethisterone which has weak androgenic, anabolic, progestational, and glucocorticoid activities. Used in the treatment of - Endometriosis Fibrocystic breast disease Gynecomastia Menorrhagia Precocious puberty Hereditary angioedema Side effect Androgenic side effects Acne hirsutism decreased breast size deepening of voice edema weight gain</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is not a complication of the use of oral contraceptives:", "options": [{"label": "A", "text": "Intracranial hemorrhage", "correct": true}, {"label": "B", "text": "Stroke", "correct": false}, {"label": "C", "text": "Venous thrombosis", "correct": false}, {"label": "D", "text": "MI", "correct": false}], "correct_answer": "A. Intracranial hemorrhage", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Intracranial hemorrhage Oral Contraceptive Pills can cause thromboembolic complications not hemorrhagic.</p>\n<p><strong>Highyeild:</strong></p><p>Adverse effects of Oral Contraceptive Pills- Non Serious side effects- Nausea and vomiting Headache Mild Precipitate migraine Breakthrough bleeding /spotting Especially with Progestin-only pills Breast discomfort Late side effects- Weight gain, acne, increased body hair Chloasma Pruritus vulvae Carbohydrate intolerance precipitation diabetes Mood swings Mental depression Abdominal distension Serious complications - Leg vein thrombosis and pulmonary embolism Coronary and cerebral thrombosis Myocardial infarction Stroke The estrogen component is responsible Increase in blood clotting factor decreased antithrombin3 decreased plasminogen activator in the endothelium increased platelet aggregation Rise in BP Genital carcinoma Increased vaginal, breast, and cervical cancer Benign hepatomas Gallstones</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Prolonged testosterone treatment for a man results in:", "options": [{"label": "A", "text": "Increased spermatogenesis", "correct": false}, {"label": "B", "text": "Increased HDL level", "correct": false}, {"label": "C", "text": "Azoospermia", "correct": true}, {"label": "D", "text": "Increased gonadotropins", "correct": false}], "correct_answer": "C. Azoospermia", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Azoospermia Continuous and prolonged use of GnRH agonists and gonadal hormones ( testosterone, estrogen) leads to suppression of gonadal function due to inhibition of LH and FSH resulting in decreased sperm production(Azoospermia) and testicular size. Since this effect is usually reversible , it is investigated as a therapeutic approach for male contraception.</p>\n<p><strong>Highyeild:</strong></p><p>Androgen side effects- Administered to women , androgens can cause virilization , excess body hair, and menstrual irregularities. Many effects, e.g. voice change may be permanent after prolonged therapy. Acne: in both males and females Frequent, sustained, and often painful erections in males at the beginning of therapy; subside spontaneously after sometime Oligozoospermia can occur with moderate doses given for a few weeks to men with normal testosterone levels . Prolonged use may produce testicular atrophy. Precocious puberty, premature sexual behavior, and stunting of stature due to early closure of epiphysis if testosterone is given continuously to young boys for increasing stature. Salt retention and edema: especially when large doses are given to patients with heart or kidney disease. This is rare with the doses used for hypogonadism. Hepatic carcinoma: incidence is higher in patients who have received long-term methyltestosterone or other oral androgens. Gynaecomastia : In children and in patients with liver disease. This is due to the peripheral conversion of testosterone to estrogens. Dihydrotestosterone does not cause gynecomastia because it is not converted to estradiol. 17-alpha-alkyl Lowering of HDL and rise in LDL prone to stroke Cholestatic jaundice reversible on discontinuation.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A. Increased spermatogenesis- Oligozoospermia can occur with moderate doses given for a few weeks to men with normal testosterone levels . Option: B. Increased HDL level- prolonged use of testosterone causes a Lowering of HDL and a rise in LDL levels. Option: D. Increased gonadotropins -prolonged use of testosterone causes a fall in gonadotropins level due to negative feedback.</p>\n<p><strong>Extraedge:</strong></p><p>Male contraceptive- GOSSYPOL (Cotton seeds) Destroy seminiferous tubules</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Failure of oral contraceptives occurs when used with any of these except:", "options": [{"label": "A", "text": "Aspirin", "correct": true}, {"label": "B", "text": "Tetracycline", "correct": false}, {"label": "C", "text": "Phenytoin", "correct": false}, {"label": "D", "text": "Rifampin", "correct": false}], "correct_answer": "A. Aspirin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Aspirin Aspirin doesnâ€™t cause Oral contraceptive failure .</p>\n<p><strong>Highyeild:</strong></p><p>Oral contraceptive failure may occur if the following drugs are used concurrently: A) Enzyme inducers: phenytoin, phenobarbitone, primidone, carbamazepine, rifampin, ritonavir. Metabolism of estrogenic as well as progestational components is increased. B) Suppression of intestinal microflora: tetracyclines, ampicillin, etc. Deconjugation of estrogens excreted in bile fails to occur â†’ their enterohepatic circulation is interrupted â†’ blood levels fall. Treatment - Switch over to a preparation containing 50 Âµg of ethinylestradiol Use an alternative method of contraception. Rifampin is usually taken for a long time and is such a potent enzyme inducer that alternative contraception should be advised.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Identify the wrong match:", "options": [{"label": "A", "text": "Sildenafil: used in pulmonary hypertension", "correct": false}, {"label": "B", "text": "Finasteride: approved in male pattern baldness", "correct": false}, {"label": "C", "text": "flutamide: used in Hirsutism in females", "correct": false}, {"label": "D", "text": "Goserelin also approved for ovarian cancer", "correct": true}], "correct_answer": "D. Goserelin also approved for ovarian cancer", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Goserelin also approved for ovarian cancer Goserelin is approved for use in Breast cancer .</p>\n<p><strong>Highyeild:</strong></p><p>Drug Uses Sildenafil phosphodiesterase-5 inhibitor (PDE5-I) Pulmonary hypertension Male erectile dysfunction Finasteride 5-alpha reductase inhibitors Benign prostatic hyperplasia Male pattern baldness flutamide Nonsteroidal antiandrogens Hirsutism in females Adjuvant treatment of metastatic prostate cancer Goserelin gonadotropin releasing hormone (GnRH) agonist Breast cancer, Dysfunctional uterine bleeding endometriosis</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error("Questions data is empty or invalid");
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error("Failed to parse questions_json:", e);
            document.getElementById(